Dian Diagnostics Group Co Ltd (300244):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Dian Diagnostics Group Co Ltd (300244) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8284
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dian Diagnostics Group Co Ltd (Dian Diagnostics) is a medical diagnostic service provider. The company provides forensic authentication services, commercialization of diagnostic products, research and development in medical diagnostics and contract research services. It offers solutions in service marketing, forensic identification, health inspection, cold chain logistics, diagnostic technology research and development production, CRO, biological sample library and other field. Dian Diagnostics promotes the development of multi-service areas of third-party independent medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains. It provides services to medical institutions across China. The company operates through its research and development center in Zhejiang. Dian Diagnostics is headquartered in Hangzhou, China.

Dian Diagnostics Group Co Ltd (300244) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Dian Diagnostics Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Hangzhou Tigermed and Dian Diagnostics Form Joint Venture 11
Zhejiang Dian Diagnostics To Form Joint Venture In China 12
Equity Offering 13
Dian Diagnostics to Raise USD170.6 Million in Private Placement of Shares 13
Zhejiang Dian Diagnostics Raises USD157 Million in Private Placement of Shares 14
Dian Diagnostics Group Co Ltd – Key Competitors 15
Dian Diagnostics Group Co Ltd – Key Employees 16
Dian Diagnostics Group Co Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Mar 27, 2018: Metabolon and DIAN Open New Metabolomics Laboratory in China 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dian Diagnostics Group Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Dian Diagnostics Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hangzhou Tigermed and Dian Diagnostics Form Joint Venture 11
Zhejiang Dian Diagnostics To Form Joint Venture In China 12
Dian Diagnostics to Raise USD170.6 Million in Private Placement of Shares 13
Zhejiang Dian Diagnostics Raises USD157 Million in Private Placement of Shares 14
Dian Diagnostics Group Co Ltd, Key Competitors 15
Dian Diagnostics Group Co Ltd, Key Employees 16
Dian Diagnostics Group Co Ltd, Subsidiaries 17

List of Figures
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Dian Diagnostics Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Dian Diagnostics Group Co Ltd (300244):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析
    NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • East Central Energy:企業の発電所・SWOT分析2018
    East Central Energy - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Nando’s Chickenland Limited:企業の戦略的SWOT分析
    Nando's Chickenland Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Alphabet Inc:企業のM&A・事業提携・投資動向
    Alphabet Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alphabet Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Hareon Solar Technology Co Ltd (600401):電力:M&Aディール及び事業提携情報
    Summary Hareon Solar Technology Co Ltd (Hareon Solar) is a renewable energy company that manufactures and markets solar energy products. The company offers silicon cells and solar modules. Its products portfolio includes mono crystalline silicon solar cells, poly crystalline silicon solar cells, pol …
  • SKF AB:企業の戦略・SWOT・財務分析
    SKF AB - Strategy, SWOT and Corporate Finance Report Summary SKF AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • China Shipbuilding Industry Corp:企業の戦略・SWOT・財務情報
    China Shipbuilding Industry Corp - Strategy, SWOT and Corporate Finance Report Summary China Shipbuilding Industry Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Ceres Nanosciences Inc:製品パイプライン分析
    Summary Ceres Nanosciences Inc (Ceres Nanosciences) is a provider of sample preparation products and diagnostic tests. The company offers Nanotrap particles for research and development and Nanotrap lyme antigen test that are protein enrichment toolset that can be integrated seamlessly into any exis …
  • Coloplast AS (COLO B):企業の財務・戦略的SWOT分析
    Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ophir Energy Plc (OPHR):石油・ガス:M&Aディール及び事業提携情報
    Summary Ophir Energy Plc (Ophir) is an independent upstream oil and gas company, which explores for and develops oil and gas properties. The company has working interests in assets across Africa and Asia. Ophir has assets in Tanzania, Equatorial Guinea, Kenya, Cote d’Ivoire, and Gabon in Africa; and …
  • Colorlab Custom Cosmetics, Inc:企業の戦略・SWOT・財務情報
    Colorlab Custom Cosmetics, Inc - Strategy, SWOT and Corporate Finance Report Summary Colorlab Custom Cosmetics, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Mercury NZ Ltd:発電所・企業SWOT分析
    Mercury NZ Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Graham Holdings Company:企業の戦略・SWOT・財務分析
    Graham Holdings Company - Strategy, SWOT and Corporate Finance Report Summary Graham Holdings Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Resonance Health Ltd (RHT):企業の財務・戦略的SWOT分析
    Summary Resonance Health Ltd (Resonance Health) is a healthcare solution provider that offers non-invasive medical imaging software and services. The company offers FerriScan analysis software for the measurement of liver iron concentration (LIC); FerriScan with Cardiac T2* dual analysis service to …
  • Pilgrim’s Pride Corp (PPC):企業の財務・戦略的SWOT分析
    Pilgrim's Pride Corp (PPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Karachaganak Petroleum Operating BV:企業の戦略的SWOT分析
    Karachaganak Petroleum Operating BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • SK E&S Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary SK E&S Co Ltd (SK E&S) a subsidiary of SK Holdings Co Ltd is a utility service provider that offers natural gas and electricity distribution. The company’s business activities include city gas, district energy, power, overseas business and LNG. It operates and supplies electricity from its L …
  • Crown Van Gelder N.V.:企業の戦略・SWOT・財務分析
    Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report Summary Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Zygo Corporation:企業の戦略的SWOT分析
    Zygo Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • KBR Inc (KBR):企業の財務・戦略的SWOT分析
    KBR Inc (KBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆